Crystallographic and electron microscopy studies revealed genuflexed (bent) integrins in both unliganded (inactive) and physiologic ligand-bound (active) states, suggesting that local conformational changes are sufficient for activation. Herein we have explored the role of local changes in the contact region between the membrane-proximal β−tail domain (βTD) and the ligand-binding βA domain of the bent conformation, in regulating interaction of integrin CD11b/CD18 (αMβ2) with its physiologic ligand iC3b. We replaced the βTD CD loop residues D658GMD of the CD18 (β2) subunit with the equivalent D672SSG of the β3 subunit, with AGAA or with NGTD, expressed the respective heterodimeric receptors either transiently in epithelial HEK293T cells or stably in leukocytes (K562), and measured their ability to bind iC3b and to conformation-sensitive mAbs. In the presence of the physiologic divalent cations Ca 2+ plus Mg 2+ (at 1mM each), the modified integrins showed increased (in HEK293) or constitutive (in K562) binding to iC3b, compared to wild-type receptors. K562 expressing the βTD-modified integrins bound in Ca
Introduction
Integrins are αβ heterodimeric receptors normally expressed in an inactive state on the cell surface but can switch rapidly and reversibly to the active physiologic ligand binding state, in response to inside-out activation signals generated from within cells (reviewed in 1 ) . The integrin ectodomain consists of a "head" segment on top of two "leg" segments 2,3 ( Figure 1 ). The head segment is formed of a seven-bladed β-
propeller from the α-subunit that associates noncovalently with a von Willebrand factor type A (vWFA) domain (βA or I-like) from the β-subunit. The α-subunit leg is formed of an Ig-like "thigh" domain followed by two large β-sandwich domains, calf-1 and calf-2. The β-subunit leg is formed of an Ig-like "hybrid" domain inserted into the n-terminal PSI domain 4, 5 , followed by four EGF-like domains and a novel beta tail domain (βTD) 2 ( Figure 1 ). In native integrins, each leg terminates in a single membranespanning segment and a short cytoplasmic tail. The prototypical ligand Arg-Gly-Asp binds to the head segment such that the ligand aspartate engages βA through a metal ion coordinated at the metal-iondependent-adhesion site (MIDAS) and the ligand arginine fits an adjacent pocket in the propeller 3 . Onehalf of the integrin α-subunits have an additional vWFA domain (αA or I), inserted between blades 2 and 3 of the propeller. αA exists in inactive and active conformations, and the α1 helix, the βF-α7 (F/α7) loop and α7 helix are known to be involved in this transition [6] [7] [8] . In the active conformation of αA-containing integrins, a c-terminal glutamate from active αA ligates the βA MIDAS, stabilizing the high affinity state 9 .
Integrins assume a compact conformation, bent at its αβ "knees" -these are located between the thigh and calf-1 domains of the α-subunit and presumably EGF1 and EGF2 of the β-subunit-such that the head contacts the lower legs of the same molecule 2 . Earlier electromicroscopy (EM) images showing genustraightened integrins 10 led to the early suggestion that inside-out activation (induction of physiologic ligand-competency) takes place as a result of a switch from the bent to the linear state 11 . Additional studies have shown, however, that such as global change is not required for switching to high binding affinity [12] [13] [14] [15] , suggesting that local changes may be sufficient to enable physiologic ligand-binding in the bent state (reviewed in 16 ). In the crystal structure of the unliganded αVβ3 ectodomain 2 , the βA and hybrid domains make discontinuous intramolecular contacts with the βTD, covering a combined ~334 Å of surface area. In , the heterodimer-specific mAb IB4 (IgG2a) 19, 20 , and a polyclonal anti-CD18 antibody 21 Medium (IMDM, CellGro) supplemented with 10% heat-inactivated fetal bovine serum and 50 IU/ml penicillin and streptomycin, at 37˚C and resuspended in serum-free IMDM at ~1 X 10 7 /ml. A total of 0.5 ml of cells were transferred into a 0.4-cm cuvette (Fisher), and 10µg of CD11b WT-and 10µg of WT or mutant CD18 cDNA were added. Electroporation was carried out at 960 µF and 320VC (Gene-Pulser, BioRad Labs). Transfectants were allowed to recover in serum-containing media for 48 h and were then selected with 1mg/ml G418 (GIBCO BRL) for up to two weeks. CD11b/CD18 expressing cells were enriched by FACS Sorting (on BD FACS Sort) using the heterodimer-specific mAb IB4 20, 26 . Sorted cells were cloned by limiting dilution and clones with similar levels of integrin expression were identified by flow cytometry for further analyses. WT and mutant K562 were maintained in IMDM supplemented with 10% heat-inactivated fetal bovine serum, 50 IU/ml penicillin and streptomycin and 1mg/ml G418. K562 cells stably-transfected with WT CD11b/CD18 using the expression plasmid EE6 hCMV carrying a G418-resistance marker were also provided by Dr. D. Simon 27 , with similar results.
Preparation of Complement iC3b-coated Sheep Erythrocytes (EiC3b). Sheep erythrocytes (E) coated
with complement iC3b were prepared using human serum following published protocols 28 . A slight modification was made in that Hank's Balanced Buffer Solution (HBSS, Gibco BRL) was used instead of the VBSG buffer. Coated and biotinylated erythrocytes (EiC3b and E) were diluted to a concentration of 1.5-6x10 7 cells/ml for the ligand-binding assay.
Antibody and Ligand Binding to HEK293 Cells. Binding of mAbs and EiC3b to transiently transfected HEK293 cells was performed in parallel in 48-well plates as described 9 . Integrin cell surface expression was analyzed using anti-CD11b and anti-CD18 mAbs. Briefly, triplicate wells containing confluent 6 monolayers of transfected cells, approximately 48 hours post-transfection, were incubated with primary mAbs (10µg/ml) in DMEM buffer containing 0.1% gelatin and 0.02% sodium azide for 1 hour at 4˚C.
Binding assays with mAb KIM127 were performed for 30min at 37˚C as described 22, 29 for expression using mAb IB4 as previously described 30 .
Immunoprecipitations. Immunoprecipitation followed by a western blot analysis was carried out to confirm heterodimerization of WT and mutant CD11b/CD18 integrins on the surface of transfected cells. overnight at 4°C. The concentration of iC3b used for these experiments fell on the steep portion of the dose-response curve (not shown). After coating with iC3b, the wells were washed with TBS and nonspecific sites were blocked by incubation with 2% non-fat milk in TBS at room temperature for 30min. The wells were washed three times with TBS and the plates were immediately used in adhesion assays. K562 cells (30,000) were transferred to each well and incubated at room temperature for 30 min in the presence of 1mM each of Ca 2+ +Mg 2+ , 1mM Mn 2+ or 5mM EDTA in a total volume of 100µL. Following a washing step, the adherent cells were fixed with formaldehyde (1.1%v/v final concentration), washed three more times with TBS and the adherent cells were fluorescently labeled with DAPI (0.5µM final in TBS with 8 0.1% TritonX-100) and quantitated using automated microscope (CellWorx automated microscope, Cellomics, PA) set at 0.3s exposure using DAPI filter set to capture 1-3 images per well. Digitized photomicrographs were then analyzed using MetaXpress image analysis software (Molecular Devices, CA) using the built-in cell count module to quantify nuclear staining. Data output files were analyzed using MS Excel.
Cell spreading Assay. 384-well Maxisorp microtiter plates coated with 5µg/ml iC3b ligand were prepared as described above. K562 cells (20,000) were transferred to each well and incubated at room temperature for 1.5 hours in serum-free IMDM, then processed as above and cell spreading visualized (>200 cells examined in multiple fields) using phase-contrast microscopy. Spreading results are reported as histograms representing mean + SD of triplicate determinations from three separate experiments.
Results
Expression of mutant forms of CD11b/CD18 in HEK293 cells. We modified the βTD's CD loop residues D658GMD of WT CD18 (Figure 1 , inset) by swapping them with the equivalent D672SSG residues of the β3-subunit. The D658GMD sequence was also replaced with AGAA or with NGTD (to fashion a neo N-glycan at N658). We assessed transient expression of mutant CD11b/CD18 integrins on the surface of HEK293 cells, which lack endogenous CD11b/CD18, using the heterodimer-specific mAb IB4 and the CD11b-specific mAb 44a. Figure 2A shows that all three CD loop mutants were expressed on the surface of HEK293 cells but at reduced levels (~50% of that of the WT integrin). Both the 44a and IB4 mAbs registered a similar level of integrin expression, which suggests that the expressed integrins are in their heterodimeric form. We further verified integrin heterodimer formation by immunoprecipitation from detergent HEK293 cell lysates with mAb 44a followed by western blotting using polyclonal anti-CD18 antibody ( Figure 2B ). Autoradiograph of the western blot shows the presence of comparable amounts of CD18 in immunoprecipitates from HEK293 cells expressing WT or mutant integrins (Lanes 1-4), suggesting that equivalent amounts are being synthesized. The slower mobility of the NGTD CD18 mutant (lane 4) is consistent with the attachment of a neo N-glycan at the introduced site 13 . No CD18 was seen in anti-CD11b immunoprecipitates from mock-transfected HEK293 cells (lane 5).
The βTD-modified CD11b/CD18 integrins are active in HEK293. Binding of CD11b/CD18 to its physiologic ligands including iC3b is divalent-cation and activation-dependent 30, 33 . We therefore used the 9 iC3b ligand to assess the functional impact of modifying the βTD CD loop in the CD11b/CD18 mutants expressed on the surface of HEK293 in the physiologic divalent cations (Ca 2+ plus Mg 2+ , each at 1mM). A portion of the WT CD11b/CD18 expressed on HEK293 assumes the active state 34 , explaining its intrinsic binding to EiC3b ( Figure 2C) . Binding of the βTD mutants to EiC3b increased by 2-3 fold above that of the WT receptor (set empirically at 100%) ( Figure 2C ). This level of binding did not increase further by the activating cation Mn 2+ (at 1mM) ( Figure 2C ), commonly used as a mimic of inside-out integrin activation (reviewed in 1 ) , suggesting that the majority of the expressed receptors are already activated.
The βTD-modified CD11b/CD18 is constitutively active in K562. The nature of the conformational changes that may occur in parallel with the high affinity (physiologic ligand binding state) were next examined in more detail in the βTD mutants expressed stably in K562 cells. K562 cells express WT integrins in a default low affinity state as in normal leukocytes 35 , which can be activated by inside-out signals primarily through a change in integrin affinity rather than avidity 36 , thereby providing a more relevant context to observe changes in the level of integrin activation 35 . K562 cells expressing equivalent levels of heterodimeric WT and mutant CD11b/CD18 ( Figure 3A) were examined for their ability to bind iC3b (covalently bound to the surface of erythrocytes using fresh serum, as in the physiologic state) or adsorbed to microtiter plastic plates. In the presence of the physiologic divalent cations, binding (rosette formation) of the mutant CD11b/CD18 receptors to EiC3b in suspension was constitutive, unlike that of the WT, which was minimal (≤20%). Mn 2+ increased the level of binding of the WT to the same degree seen in the mutants in physiologic cations, but did not induce a further increase in EiC3b binding by the mutants (Figure 3B ), indicating that the respective integrin mutants are maximally activated in this assay, as in HEK293. We also performed a titration with increasing numbers of EiC3b to a constant concentration of WT, NGTD or mock K562 cells. Results, presented in Figure 3C , show that even at very low numbers of EiC3b (and thus, a low EiC3b/K562 cell ratio), the mutant NGTD-expressing K562 cells showed higher binding to EiC3b in physiologic cations compared to WT-expressing cells. These differences were most pronounced at an EiC3b/K562 cell ratio of ~18. While Mn 2+ produced the expected increase in binding of WT-expressing K562 to EiC3b, no increase in EiC3b binding to the NGTD mutant took place at any
EiC3b/K562 cell ratio tested.
We also evaluated ligand binding under conditions in which CD11b/CD18-expressing K562 were allowed to bind ligand adsorbed onto microtiter plastic plates. The specificity of the interaction was again reflected in the lack of binding of mock K562 or WT CD11b/CD18 expressing K562 in the presence of the physiologic divalent cations ( Figure 4A ), while 1mM Mn 2+ was sufficient to induce maximal binding by the WT receptor. K562 expressing the βTD mutant CD11b/CD18 receptors all showed significant binding to immobilized iC3b in the presence of physiologic cations. However and in contrast to the rosetting assay and the binding assay in HEK293, there were small but significant differences in the magnitude of the response to the addition of Mn 2+ ; in the case of the NGTD mutant, Mn 2+ produced only a modest increase in iC3b binding above that seen in Ca 2+ +Mg 2+ , but the increase was more in the case of the DSSG and even higher in the case of the AGAA mutant ( Figure 4A ).
The CD11b/CD18 βTD mutants show increased cell spreading. To determine whether the activating βTD mutations also modify outside-in signaling, we measured cell spreading on iC3b-coated plates in the presence of Ca 2+ +Mg 2+ (1mM each). Both mock and WT CD11b/CD18-expressing K562 cells showed minimal cell spreading (Figures 4B-C). All three βTD mutants showed increased cell spreading, with the NGTD mutant presenting the maximal level of spreading, followed by DSSG and AGAA.
Reactivity of βTD-modified CD11b/CD18 with conformationally sensitive mAbs. We next used mAbs to probe the conformational state of the expressed mutants in K562. mAb 24 is widely used as a reporter of the high affinity state in β2 integrins 23 . It binds to an activation-and cation-dependent epitope in βA, which includes residues Arg122 of the α1' helix and Glu175 in the specificity determining loop (SDL) 31 ( Figure 1) . We assessed the binding of this mAb to WT-and mutant CD11b/CD18 expressed on K562.
AGAA, DSSG and NGTD mutants showed a significant increase in binding to mAb24 compared to WT ( Figure 5 ). The magnitude of this increase was similar to that observed in maximally activated β2 integrins expressed in K562 37 or in Jurkat cells 38 . In the presence of Mn 2+ , the reactivity of mAb 24 with WT increased by ~3-fold, compared to the 1.5-1.8 fold increase seen in the case of the mutant integrins ( Figure   5 ).
mAb KIM127 binds an epitope in the EGF2 domain in genu-straightened β2-inetgrins 39 , and has therefore been used as a marker of this state 40 . Since WT CD11b/CD18 is largely inactive when expressed on K562, whereas all three mutants are constitutively active as judged by the iC3b binding assays, we tested mAb KIM127 binding to WT and βTD mutant receptors in physiologic Ca 2+ +Mg 2+ . There was no significant 11 difference in the level of binding of mAb KIM127 to the constitutively active βTD mutants vs. the WT receptor ( Figure 6 ). Reactivity of mAb KIM127 to the WT integrin was doubled in the presence of 1mM Mn 2+ , a level of increase consistent with previous reports 38 . Interestingly, Mn 2+ produced an equivalent increase in binding of mAb KIM127 to each of the three βTD mutants ( Figure 6 ).
Discussion
Previous studies in the ligand-binding integrin αA domain have shown that the transition from the inactive to the active state involves coordinated changes in the α1 helix, the F/α7 loop and α7 helix (reviewed in 41 ). Small molecules or certain mAbs that bind in the F/α7 region allosterically block ligand binding 42, 43 .
The membrane-proximal βTD in the bent integrin contacts βA in the F-α7 region; replacing the contact residues S674 (from the βTD CD loop) and V332 (from the βA F-strand) with cysteines creates a disulphide bridge that locks the membrane-bound integrin in the low affinity state 11, 44 . Here we show that modifications of the CD loop in the β2 integrin CD11b/CD18 are activating, suggesting that the βTD acts as an allosteric regulator of ligand binding in this integrin. Constitutive activation of the integrin by the CD loop mutations also led to a proportional increase in cell spreading on iC3b-coated surfaces, an outside-in signaling response.
The crystal structure of the bent integrin shows that the βA F/α7 loop is also stabilized in the low affinity state, through an ADMIDAS metal ion-mediated bridge to the α1 helix, which prevents the inward movement of this helix and the restructuring of the F/α7 loop during activation (Figure 1 , inset)(reviewed in 41 ). This link is unique to βA domains (vs. the αA domains) and is broken in the crystal structure of the RGD-bound bent integrin ectodomain 3 . Mutational removal of this link also generates constitutively active bent β2 integrins, but impairs cell spreading (data not shown and 45 ), the latter effect perhaps reflective of the need for the ADMIDAS ion in stabilizing the liganded (signaling) integrin state as well 41 . Other studies have shown that swapping of the βA's F/α7 loop residues in β2 with those in the β1-subunit or replacing certain residues with alanine induced the high affinity state in the respective integrin 46, 47 . Taken together, these data argue that local conformational changes taking place within βA or its contact with the βTD are sufficient to switch the integrin to high binding affinity.
Binding of K562-expressing βTD mutants to EiC3b in suspension was equivalent in the presence of physiologic Ca 2+ +Mg 2+ or Mn 2+ , over a broad range of ligand concentrations ( Figure 3B, C) . This was also the case when EiC3b was allowed to bind to adherent HEK293 cells ( Figure 2C Figure 4A ). Also, Mn
2+
further increased the constitutive binding of the affinity reporter mAb24 to all three βTD mutants ( Figure   5 ). One interpretation of these findings is that the βTD mutations increase both receptor avidity as well as affinity. It is known however that the change in physiologic ligand binding to integrins expressed in K562 reflects an affinity rather than an avidity switch 36 . If a change in avidity is also operational, it is more likely to impact integrin binding to the plastic adsorbed purified ligand. A second interpretation is that the AGAA and DSSG mutants may exert a priming effect, enhancing the transition from the low-to the high- Figure 4A ). It is also known that mAb24 reports ligand-occupied βA 48 -in αA-containing integrins, the endogenous high affinity αA domain engages the βA MIDAS through the MIDAS cation, which allows αA to then bind exogenous physiologic ligands like iC3b (the ligand relay model) 9 . Thus, the Mn 2+ -induced further increase in binding of mAb24 (vs. iC3b ligand) to the NGTD mutant may reflect the preferential coordination of αA-occupied βA by Mn 2+ at MIDAS, in comparison to Mg 2+ or Ca 2+ .
It could be argued that more complete activation of CD11b/CD18 by the NGTD mutation may be the result of the bulky sugar moiety breaking the additional contacts the βTD makes with the hybrid domain 2 ( Figure   1 ), resulting in head-leg separation, genu-straightening and the opening of the βA/hybrid hinge, all believed to be features of the high affinity state 13, 39 . However, mAb KIM127, used as the reporter of the genustraightened conformation of the integrin 31 did not bind to the βTD mutants, in particular NGTD, in the 13 presence of Ca 2+ +Mg 2+ ( Figure 6 ). Mn 2+ exposed the KIM127 eiptope in both WT and the βTD mutants to the same degree. This finding together with the physiologic ligand binding data suggests that integrin activation can take place in the absence of genu-straightening, which has been linked to the opening of  the βA/hybrid hinge. Consistently, the high binding affinity ADMIDAS-defective CD11a/CD18 integrin was also found to be poorly reactive with KIM127 45 , and fluorescence lifetime imaging (FLIM) analysis in intact K562 cells in the presence of physiologic cations shows that the ligand-binding site in WT and the NGTD mutant CD11b/CD18 is unchanged relative to the lipid bilayer, arguing against genu-straightening induced by this mutation (manuscript in preparation). Finally, a recent molecular dynamics study 49 found that the activating inward shift of the βA α1 helix can be achieved with a very modest ~20 o opening of the βA/hybrid hinge; an increase of this magnitude can be accommodated in the ligand-bound bent conformation 14 .
The results presented here add new insights into the allosteric pathways resulting in the integrin-activated state ( Figure 7 ). In the low-affinity state, the integrin is likely expressed on the cell surface in a bent conformation ( Figure 7A ), stabilized by head to leg contacts, inclusive of the membrane-proximal βTD.
Conformational changes in the cytoplasmic tails and transmembrane helices, generated by inside-out activation, likely produce a βTD/βA hinge opening ( Figure 7B ), which switches the integrin βA to the high affinity binding state, manifested by the restructuring of the F/α7 loop, disrupting ADMIDAS which permits the activating inward movement of the α1 helix needed to create as stable ligand-binding MIDAS.
We In conclusion, we have shown that the βTD CD loop in the bent CD11b/CD18 integrin is functionally relevant, playing an important role in inside-out integrin activation, as proposed in the deadbolt model 32 .
Additional accumulating evidence may now be explained in this light (reviewed in 41, 50 ). For example, creating a disulphide linkage between the βTD and calf-2 has been shown to block activation 44 ; this may prevent the βTD/βA hinge movement. Similarly, mutation of each of the four cysteine pairs present in the 14 βTD domain revealed that only C663-C687 in the β3-subunit, located at the base of the CD loop five residues away from the TM segment (Figure 1 ), is activating when interrupted 50 . Of interest in this regard is that the βTD's CD loop and the strands, inclusive of the stabilizing disulphide at its base, are naturally absent in the β8-subunit in vertebrates 51 ; the present data suggest that these modifications may prime or activate the respective β8 integrin. (magenta) links the α1'-α1 helix and F/α7 loop through D126D127 and M335 (equivalent to D119D120, E325 in the β2-subunit, respectively)(Cα is in green and oxygens are in red). S123 in β3 (and S116 in β2)
complete the metal coordination sphere. 
